NEWS DETAIL

  • Source : Press Release
  • Date : 2021-08-17
  • Companies : Tosoh Corp.

Tosoh Bioscience Celebrates 50th Anniversary of the TSKgel Column Brand

Tokyo, Japan—Tosoh Bioscience, a provider of chromatographic solutions to the pharmaceutical, biotechnology and chemical industries, is excited to announce the 50th anniversary of the introduction of the TSKgel U/HPLC column line. In 1971, Tosoh (known then as Toyo Soda Kogyo, i.e. the brand’s “TSK” original meaning) launched its first gel permeation chromatography (GPC) column for organic-soluble polymer analysis, the TSKgel S-type, a polymer-based column.

TSKgel S-type columns paved the way for an entire suite of columns in nearly every mode of liquid chromatography. Size exclusion chromatography has remained a special focus in the product line, with the TSKgel SW series as the biopharma industry’s first choice for QC of therapeutic antibodies. Whether your needs are basic biological research, drug discovery, medicinal chemistry, agriculture, manufacturing, or other industrial applications, Tosoh Bioscience has the optimal solution. 

As the science and technology of liquid chromatography continues to evolve, we at Tosoh Bioscience will continue our rich history of innovation through our TSKgel columns.

TOSOH BIOSCIENCE

Tosoh Bioscience provides liquid chromatography products to laboratories and manufacturing plants globally. While the majority of our customers work in biotechnology and pharmaceutical companies, our HPLC columns and systems are essential tools for sample analysis in most industries. The LenS®3 Multi-Angle Light Scattering Detector offers a revolutionary approach for the direct measurement of absolute molecular weight of macromolecules. Our ambient and high temperature EcoSEC® GPC Systems are predominantly used in the chemical and polymer industries. In the field of biotechnology, our preparative chromatography resins play a critical role in the purification of therapeutic proteins and nucleic acids.

Tosoh Bioscience is a division of Tosoh Corporation, the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 12,000 people and generated net sales of ¥732.9 billion (US$6.9 billion at the average rate of ¥106.1 to the US dollar) in fiscal 2021, ended March 31, 2021.

For more information, please contact your regional Tosoh Bioscience office:

In Japan: [email protected]
In China: [email protected]
In Singapore: [email protected]
In India: [email protected]
In Europe: [email protected]
In the Americas: [email protected]

The Tosoh Corporate mark, Tosoh Bioscience, TSKgel and EcoSEC are registered trademarks of Tosoh Corporation. LenS is a registered trademark of Tosoh Bioscience LLC in the USA, India and Japan.

TOSOH CORPORATION

Who We Are

Tosoh Corporation is the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 12,000 people. It generated net sales of ¥732.9 billion (US$6.9 billion at the average rate of ¥106.1 to the US dollar) in fiscal 2021, ended March 31, 2021.

What We Do

Tosoh is one of the largest chlor-alkali manufacturers in Asia. The company supplies the plastic resins and an array of the basic chemicals that support modern life. Tosoh’s petrochemical operations supply ethylene, polyethylene, and functional polymers, while its advanced materials business serves the global semiconductor, display, and solar industries. Tosoh has also pioneered sophisticated bioscience systems that are used for the monitoring of life-threatening diseases. In addition, Tosoh demonstrates its commitment to a sustainable future in part by manufacturing a variety of eco-products.

Stock Exchange Ticker Symbol: 4042

DISCLAIMER

This document may contain forward-looking statements, including, without limitation, statements concerning product development, objectives, goals, and commercial introductions, which involve certain risks and uncertainties. Forward-looking statements are identified through the use of the word anticipates and other words of similar meaning. Actual results may differ significantly from the results expressed in forward-looking statements.